Providers/Grant Support

This activity is provided by Med Learning Group.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Credits Available

Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
Physician Associates — maximum of 1.5 AAPA Category 1 CME Credits™
Nurses — 1.5 Nursing Contact Hours
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION- 1.5 ACPE

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of healthcare professionals, nationally, including medication prescribers and care team members; physicians (including primary care, internal medicine, emergency medicine, surgery, pain medicine, addiction medicine), advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.

Program Overview

This REMS-compliant program is designed to enhance clinician confidence and competence in the safe and effective management of pain. Through evidence-based instruction and expert-led discussion, participants will gain practical strategies for conducting comprehensive pain assessments, developing guideline-driven treatment plans, and integrating nonpharmacologic and non-opioid pharmacologic therapies into patient care. The curriculum also addresses best practices in opioid prescribing and patient counseling, appropriate specialist referrals, and current protocols for recognizing and managing opioid use disorder.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Articulate the foundational elements of pain management, distinguishing between definitions, classifications, and mechanisms of pain
Conduct comprehensive pain assessments that evaluate pain severity and identify patient-specific risk factors for nonmedical opioid use and opioid use disorder
Apply effective strategies for managing acute and chronic pain that prioritize the use of nonpharmacologic and non-opioid pharmacologic modalities
Develop guideline-driven strategies for initiating, titrating, and discontinuing opioid analgesics, while emphasizing individualized treatment plans, secure storage protocols, and counseling approaches for patients and caregivers concerning naloxone use during opioid overdose
Recognize clinical indicators for specialist referral and facilitate timely consultations with pain management and addiction medicine
Outline the core principles of addiction medicine and apply evidence-based strategies for recognizing and managing opioid use disorder

Faculty

Joseph Teel, MD

Chief, Regional Primary Care for Penn Medicine Medical Group
Advisory Dean, Perelman School of Medicine
Professor of Clinical Family Medicine and Community Health
Philadelphia, Pennsylvania

Michael Ashburn, MD, MPH

Professor of Anesthesiology and Critical Care
Penn Pain Medicine Center
Philadelphia, PA

Judy Chertok, MD, FAAFP

Penn Family Care
Associate Professor
Program Director, Addiction Medicine Fellowship
Director of Addiction Medicine
Department of Family Medicine Community Health
Philadelphia, PA

Nicole O’Donnell

Director-Center for Addiction Medicine and Policy
Certified Recovery Specialist
Penn Medicine
Philadelphia, PA.

Accreditation Statement

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.

PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS

Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1.5 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designed for 1.5 AAPA Category 1 CME credit. Approval is valid until 1/23/2027. PAs should only claim credit commensurate with the extent of their participation.

ACCME Innovation Partner

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify

Disclosure of Relevant Financial Relationships

All relevant financial relationships have been mitigated.

Instructions for Participation and Credit

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Contact Information